{
    "title": "Individual feed for https://www.2minutemedicine.com/feed/",
    "link": "https://www.2minutemedicine.com/feed/",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-09-04T18:02:21.041201",
    "items": [
        {
            "title": "Novo’s self replicating RNA push expands cardiometabolic pipeline",
            "link": "https://www.2minutemedicine.com/novos-self-replicating-rna-push-expands-cardiometabolic-pipeline/",
            "description": "1. Novo Nordisk expanded into self replicating RNA for obesity and T2D (type 2 diabetes), signaling modality diversification beyond peptides. 2. The c...",
            "pubDate": "2025-09-04T15:00:02",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2013/07/US_Navy_110727-N-YR391-005_Lt._Cmdr._Jennifer_Freeman_an_Obstetrics-Gynecology_physician_at_Naval_Hospital_Jacksonville-300x150.jpg"
        },
        {
            "title": "Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab",
            "link": "https://www.2minutemedicine.com/long-term-outcomes-of-patients-with-crohns-disease-treated-with-risankizumab/",
            "description": "1. In adult patients with Crohn’s disease (CD) treated with risankizumab, only 13% of patients experienced treatment failure while 23% of patients req...",
            "pubDate": "2025-09-04T00:00:59",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2018/12/Crohn_Colitis_6264520294-300x150.jpg"
        },
        {
            "title": "2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]",
            "link": "https://www.2minutemedicine.com/2-minute-medicine-pharma-roundup-obesity-rna-deal-at-home-alzheimers-dosing-oncology-royalty-financing-and-first-brutons-tyrosine-kinase-inhibitor-for-immune-thrombocytopenia-s/",
            "description": "Novo’s srRNA push expands cardiometabolic pipeline On August 28, Novo Nordisk announced a collaboration with Replicate Bioscience to pursue self repli...",
            "pubDate": "2025-09-03T16:50:58",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-300x200.png"
        },
        {
            "title": "Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study",
            "link": "https://www.2minutemedicine.com/menin-inhibition-with-revumenib-for-npm1-mutated-relapsed-or-refractory-acute-myeloid-leukemia-the-augment-101-study-1-in-pretreated-patients-with-nucleophosmin-1-mutated-npm1m-acute-myeloid-leuke/",
            "description": "1. In pretreated patients with nucleophosmin 1-mutated (NPM1m) acute myeloid leukemia (AML), nearly half of patients treated with revumenib showed a c...",
            "pubDate": "2025-09-03T00:00:12",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2017/03/chronic-myelogenous-leukemia-300x150.jpg"
        },
        {
            "title": "An absence of cardiovascular risk factors is linked to over ten additional healthy years",
            "link": "https://www.2minutemedicine.com/an-absence-of-cardiovascular-risk-factors-is-linked-to-over-ten-additional-healthy-years/",
            "description": "1. In this large global cohort study, individuals aged 50 without five major cardiovascular risk factors (hypertension, hyperlipidemia, abnormal body ...",
            "pubDate": "2025-09-02T15:00:01",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2018/02/cardiac-heart-300x150.jpeg"
        }
    ]
}